Compare Stocks: SNAL, AVNS, GCL, and IH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$24.99	$24.98	$9.30 ▼ $25.49	$1.17B	1.57	700,357 shs	N/A
GCL GCL Global	$0.61 +6.2%	$0.52	$0.38 ▼ $3.20	$77.91M	0.39	612,540 shs	202,874 shs
IH iHuman	$1.21 +0.4%	$1.33	$1.20 ▼ $3.16	$61.59M	0.17	11,968 shs	4,008 shs
SNAL Snail	$2.58 +0.8%	$3.77	$1.70 ▼ $10.80	$23.11M	1.22	68,310 shs	17,537 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	0.00%	0.00%	0.00%	+0.10%	+107.51%
GCL GCL Global	+6.21%	+12.70%	+20.28%	+48.40%	-79.91%
IH iHuman	-1.55%	-1.63%	-12.68%	-12.36%	-58.80%
SNAL Snail	+0.78%	+1.98%	-11.34%	-27.73%	-40.78%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$24.99	$24.98	$9.30 ▼ $25.49	$1.17B	1.57	700,357 shs	N/A
GCL GCL Global	$0.61 +6.2%	$0.52	$0.38 ▼ $3.20	$77.91M	0.39	612,540 shs	202,874 shs
IH iHuman	$1.21 +0.4%	$1.33	$1.20 ▼ $3.16	$61.59M	0.17	11,968 shs	4,008 shs
SNAL Snail	$2.58 +0.8%	$3.77	$1.70 ▼ $10.80	$23.11M	1.22	68,310 shs	17,537 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	0.00%	0.00%	0.00%	+0.10%	+107.51%
GCL GCL Global	+6.21%	+12.70%	+20.28%	+48.40%	-79.91%
IH iHuman	-1.55%	-1.63%	-12.68%	-12.36%	-58.80%
SNAL Snail	+0.78%	+1.98%	-11.34%	-27.73%	-40.78%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	1.50	Reduce	N/A	N/A
GCL GCL Global	1.00	Sell	N/A	N/A
IH iHuman	1.00	Sell	N/A	N/A
SNAL Snail	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest SNAL, AVNS, GCL, and IH Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/10/2026	GCL GCL Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
9/10/2026	SNAL Snail	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/27/2026	SNAL Snail	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/25/2026	GCL GCL Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
8/14/2026	SNAL Snail	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
8/11/2026	GCL GCL Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
8/7/2026	SNAL Snail	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/20/2026	AVNS Avanos Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	GCL GCL Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
7/6/2026	SNAL Snail	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/2/2026	SNAL Snail	Noble Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform

(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$715.90M	1.64	$3.42 per share	7.30	$16.73 per share	1.49
GCL GCL Global	$238.92M	0.33	N/A	N/A	$0.34 per share	1.79
IH iHuman	$115.40M	0.53	$0.29 per share	4.18	$2.78 per share	0.43
SNAL Snail	$81.23M	0.28	N/A	N/A	($2.90) per share	-0.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$72.90M	-$1.61	N/A	26.59	N/A	-10.39%	5.39%	3.97%	N/A
GCL GCL Global	-$25M	-$0.02	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IH iHuman	$13.64M	$0.19	6.34	N/A	N/A	9.35%	7.46%	5.40%	9/17/2026 (Estimated)
SNAL Snail	-$27.24M	-$1.26	N/A	1.64	N/A	-8.83%	-15.49%	-13.52%	11/11/2026 (Estimated)

Latest SNAL, AVNS, GCL, and IH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/17/2026	Q2 2026	IH iHuman	$0.0249	N/A	N/A	N/A	$33.94 million	N/A
8/11/2026	Q2 2026	SNAL Snail	$1.55	-$0.36	-$1.91	-$0.36	$29.00 million	$21.80 million
7/31/2026	Q4 2026	GCL GCL Global	N/A	-$0.08	N/A	-$0.08	N/A	$70.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
GCL GCL Global	N/A	N/A	N/A	N/A	N/A
IH iHuman	N/A	N/A	N/A	N/A	N/A
SNAL Snail	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS Avanos Medical	0.11	2.48	1.40
GCL GCL Global	0.80	1.52	1.13
IH iHuman	N/A	3.50	3.42
SNAL Snail	N/A	0.55	0.55

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
GCL GCL Global	36.55%
IH iHuman	4.92%
SNAL Snail	0.36%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.33%
GCL GCL Global	49.40%
IH iHuman	63.60%
SNAL Snail	66.78%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	4,040	46.85 million	45.76 million	Optionable
GCL GCL Global	N/A	128.01 million	64.77 million	N/A
IH iHuman	1,120	51.11 million	18.60 million	Not Optionable
SNAL Snail	60	8.96 million	2.98 million	Not Optionable

SNAL, AVNS, GCL, and IH Headlines

Recent News About These Companies

Battle to save the tiny, gooey snail only found in one lake in the UK

September 11 at 10:45 PM | msn.com

Tiny snail stalls Donald Trump’s Irish golf ambitions

September 11 at 5:45 PM | ft.com

Teachers clear giant African snails daily as infestation spreads beyond farms in India

September 11 at 1:03 AM | yahoo.com

A Grand Isle snail hunt: How these LSU students are studying Louisiana’s changing coast

September 10 at 3:01 PM | nola.comN

Snail, Inc. to Present at H.C. Wainwright 28th Annual Global Investment Conference

September 10 at 8:51 AM | quiverquant.comQ

Snail Games to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, at 4:00 p.m.

September 10 at 8:30 AM | globenewswire.com

Snail (NASDAQ:SNAL) Shares Up 3.2% - Time to Buy?

September 9 at 2:41 AM | americanbankingnews.com

Snail Games launches sci-fi survival title Honeycomb: The World Beyond

September 8, 2026 | proactiveinvestors.com

Snail Games Launches Honeycomb: The World Beyond Globally on PC and Console

September 8, 2026 | quiverquant.comQ

Snail Games Announces Global Launch of Honeycomb: The World Beyond Across PC and Console Platforms

September 8, 2026 | globenewswire.com

Invasive snails that clone themselves identified in Colorado lake, triggering boat checks

September 8, 2026 | msn.com

A single cone snail’s sting can be powerful enough to kill a human

September 7, 2026 | msn.com

SNAL Stock Dips 41% in a Month: Should Investors Buy, Sell, or Hold?

September 7, 2026 | zacks.com

The cone snail fires a venom harpoon strong enough to kill a person

September 6, 2026 | msn.com

Tour operators help cull 420,000 Drupella snail pests from Great Barrier Reef

September 5, 2026 | msn.com

In 1989, Detroit Zoo began helping save snails wiped out in the wild; 37 years later, 500 are travelling 5,000 miles to Tahiti, part of a program that has returned 17,000

September 4, 2026 | timesofindia.indiatimes.com

Snails ate my garden — and I learned to appreciate them: Nature News

September 1, 2026 | seacoastonline.comS

Snail Games Announces Conditional Decision by Nasdaq to Continue Listing Class A Common Stock

September 1, 2026 | markets.businessinsider.com

Snail Retains Nasdaq Listing Under Equity Compliance Conditions

September 1, 2026 | tipranks.com

Snail Games Announces Conditional Decision by Nasdaq to Continue Listing Class A Common Stock

September 1, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNAL, AVNS, GCL, and IH Company Descriptions

Avanos Medical NYSE:AVNS

$24.99 0.00 (0.00%)

As of 09/11/2026

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

GCL Global NASDAQ:GCL

$0.61 +0.04 (+6.21%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$0.59 -0.02 (-3.55%)

As of 09/11/2026 07:54 PM Eastern

GCL Global Holdings Ltd. unites people through immersive games and entertainment experiences, enabling creators to deliver engaging content and fun gameplay experiences to gaming communities worldwide with a strategic focus on the rapidly expanding Asian gaming market. Drawing on a deep understanding of gaming trends and market dynamics, GCL Group leverages its diverse portfolio of digital and physical content to bridge cultures and audiences by introducing Asian-developed IP to a global audience across consoles, PCs, and streaming platforms.

iHuman NYSE:IH

$1.20 +0.01 (+0.42%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$1.21 +0.00 (+0.41%)

As of 09/11/2026 07:30 PM Eastern

iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery. It provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.

Snail NASDAQ:SNAL

$2.58 +0.02 (+0.78%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$2.60 +0.02 (+0.78%)

As of 09/11/2026 07:30 PM Eastern

Snail, Inc., together with its subsidiaries, researches, develops, markets, publishes, and distributes interactive digital entertainment for consumers worldwide. It offers games, content, and support for various platforms, including game consoles, personal computers, mobile phones, and tablets. Snail, Inc. was founded in 2009 and is headquartered in Culver City, California. Snail, Inc. operates as a subsidiary of Olive Wood Global Development Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SNAL, AVNS, GCL, and IH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SNAL, AVNS, GCL, and IH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SNAL, AVNS, GCL, and IH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNAL, AVNS, GCL, and IH Company Descriptions

Avanos Medical NYSE:AVNS

GCL Global NASDAQ:GCL

iHuman NYSE:IH

Snail NASDAQ:SNAL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SNAL, AVNS, GCL, and IH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SNAL, AVNS, GCL, and IH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SNAL, AVNS, GCL, and IH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNAL, AVNS, GCL, and IH Company Descriptions

Avanos Medical NYSE:AVNS

GCL Global NASDAQ:GCL

iHuman NYSE:IH

Snail NASDAQ:SNAL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools